Fingerprint
Dive into the research topics of 'ENMD-2076, an oral inhibitor of angiogenic and proliferation kinases, has activity in recurrent, platinum resistant ovarian cancer'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
ENMD-2076, an oral inhibitor of angiogenic and proliferation kinases, has activity in recurrent, platinum resistant ovarian cancer
Ursula A. Matulonis*, Julie Lee, Brian Lasonde, William P. Tew, Afra Yehwalashet, Daniela Matei, Kian Behbakht, Jill Grothusen, Gini Fleming, Nita K. Lee, Jamie Arnott, Mark R. Bray, Graham Fletcher, Richard D. Brokx, Vincent Castonguay, Helen MacKay, Carolyn F. Sidor, Amit M. Oza
*Corresponding author for this work
Research output: Contribution to journal › Article › peer-review
34
Scopus
citations